Employer record no. 11377
Entrada Therapeutics, Inc.
US DOL LCA disclosure data, FY2020 to FY2026
Total LCA filings
39
Certified
39
Denied
0
FY2025 filings
7
Filings by fiscal year
* partial fiscal year; quarters still being published by DOL
Peer rank
#814 of 2,686 healthcare employers by filings
The ledger
| Fiscal year | Filed | Certified | Denied | Avg offered wage | Avg prevailing |
|---|---|---|---|---|---|
| FY2020 | 1 | 1 | 0 | $72,100 | $60,466 |
| FY2021 | 1 | 1 | 0 | $155,000 | $120,349 |
| FY2022 | 6 | 6 | 0 | $96,525 | $72,714 |
| FY2023 | 4 | 4 | 0 | $96,821 | $85,000 |
| FY2024 | 14 | 14 | 0 | $109,468 | $94,275 |
| FY2025 | 7 | 7 | 0 | $125,473 | $109,423 |
| FY2026 * | 6 | 6 | 0 | $129,785 | $111,641 |
What they file for
- research associate ii$81,46013
- scientist i$115,2676
- scientist ii$135,6204
- senior research associate$99,8933
- associate director, scientific strategy and innovation$183,1302
- senior associate ii, competitive intelligence and strategy$150,0002
- senior scientist ii$163,7482
- sr. research associate$93,7502
Where
- boston, ma39
Every number on this page is free. Members get an email when this employer files again, a CSV of the full record, and the complete rankings with state and job-title filters.
Watch this employerGet the quarterly H-1B update, free
When DOL publishes new filings we send what changed: the biggest movers and the slimmest wage premiums. No account needed. Members also get alerts for Entrada Therapeutics, Inc. and any other employer they watch.
Certification rate 100.0%How these numbers are computed